FATE THERAPEUTICS DL-,001FATE THERAPEUTICS DL-,001FATE THERAPEUTICS DL-,001

FATE THERAPEUTICS DL-,001

No trades
See on Supercharts

Price target

5.980.000.00%
The 12 analysts offering 1 year price forecasts for F6T have a max estimate of — and a min estimate of —.

Analyst rating

Based on 15 analysts giving stock ratings to F6T in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


F6T EPS for the last quarter is −0.36 EUR despite the estimation of −0.37 EUR. In the next quarter EPS is expected to reach −0.42 EUR. Track more of FATE THERAPEUTICS DL-,001 financials and stay on top of what is up with the company.
In the next quarter FATE THERAPEUTICS DL-,001 revenue is expected to reach ‪1.57 M‬ EUR. Check out FATE THERAPEUTICS DL-,001 revenue and earnings and make informed decisions.
According to analysts, F6T price target is 5.98 EUR with a max estimate of 9.44 EUR and a min estimate of 2.83 EUR. Check if this forecast comes true in a year, meanwhile watch FATE THERAPEUTICS DL-,001 stock price chart and keep track of the current situation with F6T news and stock market news.
We've gathered opinions of 15 analysts rating F6T stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.